STAT3-IN-46
STAT3-IN-46 is a selective and orally active inhibitor of signal transducer and activator of transcription 3 (STAT3) (KD = 323.3 nM) . STAT3-IN-46 directly binds to the SH2 domain of the STAT3 and inhibits IL-6/JAK/STAT3 signaling pathway (IC50 = 0.87 μM) and downregulates c-Myc and Bcl-2 levels. STAT3-IN-46 can be used for the research of cancer, such as triple-negative breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Bcl-2 Family; c-Myc; Interleukin Related; JAK; STAT
Related Pathways
Apoptosis; Epigenetics; Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Smiles
N#CC1=CC=CC(C2=NN=C(NC3=C(N4CCN(CC)CC4)C=C5N(C6CC6)C(C7=CC=C(F)C=C7)=NC5=C3)S2)=C1
Molecular Formula
C31H29FN8S
Molecular Weight
564.68
References & Citations
[1]Wang R, et al. Discovery of potent and selective STAT3 inhibitors against triple-negative breast cancer. Eur J Med Chem. 2025 Nov 15;298:118020.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bcl-2; IL-6; STAT3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Bombyx mori nuclear polyhedrosis virus Occlusion-derived virus envelope protein E56 (ODVP6E), partial
Recombinant Anti-ABHD14B Antibody, Rabbit Monoclonal